Last reviewed · How we verify

NCT03678844

Taekwondo Practice in Adolescents With Attention Deficit Hyperactivity Disorder

Completed NA Last updated 23 October 2018
What this trial tests

NA trial testing Taekwondo practice in Attention Deficit Hyperactivity Disorder in 40 participants. Completed in 17 January 2017.

Timeline
1 September 2015
Primary endpoint
1 January 2017
17 January 2017

Quick facts

Lead sponsorUniversity of Genova
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment40
Start date1 September 2015
Primary completion1 January 2017
Estimated completion17 January 2017

Drugs / interventions tested

Conditions studied

Sponsor

University of Genova

Who can join

Adults 12 to 18, any sex, with Attention Deficit Hyperactivity Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neuro-developmental/behavioral disorders among adolescents. Sport and physical activity seem to play a major role in the development of cognition, memory, selective attention and motor reaction time, especially among adolescents with ADHD. In this context, the objective of this study was to investigate the effects of a one and a half year long Taekwondo (TKD) intervention on cognitive function in adolescents with ADHD.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of Taekwondo Practice on Cognitive Function in Adolescents with Attention Deficit Hyperactivity Disorder.
    Kadri A, Slimani M, Bragazzi NL, Tod D, et al · · 2019 · cited 50× · PMID 30642062 · DOI 10.3390/ijerph16020204

Verify or expand the search:

Other recruiting trials for Attention Deficit Hyperactivity Disorder

Currently open trials in the same condition.

Other University of Genova trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03678844.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing